Zimbabwe

Zimbabwe’s health research environment comprises universities, research institutions, clinical trial sites, and independent research organizations. Oversight of ethics review is mandated to MRCZ at the national level, supported by MCAZ and several Institutional Review Boards (IRBs) situated within academic and medical institutions.

While the regulatory architecture is established, the system continues to face challenges associated with outdated legislation, inconsistent operational standards, limited technical capacity, fragmented review processes, and inadequate digital infrastructure. These constraints limit the country’s ability to fully align with global ethical and regulatory benchmarks.

Country Background

Zimbabwe is undertaking a national initiative to strengthen its health research ethics oversight system through the TRACE Project, implemented by the Medical Research Council of Zimbabwe (MRCZ) in collaboration with the Medicines Control Authority of Zimbabwe (MCAZ). Supported by the Gates Foundation, the project aims to align the country’s ethics review and regulatory framework with internationally recognized standards for quality, transparency, and accountability.

Zimbabwe’s regulatory and ethics oversight framework has evolved steadily over the past four decades, anchored in two central bodies:

  • MRCZ, mandated to provide national ethical oversight for all health research involving human participants.
  • MCAZ, mandated to regulate medicines, clinical trials, and related products, including granting scientific and regulatory approval for clinical research.

MRCZ’s role: 

MRCZ oversees ethical compliance by:

  • Accrediting and supervising Institutional Review Boards (IRBs)
  • Reviewing and approving health-related research
  • Conducting monitoring visits and continuing review
  • Protecting the rights, safety, and well-being of human research participants

MCAZ’s role: 

MCAZ regulates clinical trials and medical products through:

  • Evaluation and approval of clinical trials
  • Inspection of research sites
  • Post-market surveillance
  • Ensuring safety, efficacy, and quality of medicines

KPIs and Milestones

This achievement signifies that:

  • The national regulatory authority (MCAZ) has a stable, well-functioning and integrated regulatory system
  • Regulatory processes meet internationally acceptable performance benchmarks
  • Zimbabwe is positioned to move towards the WHO Listed Authority (WLA) pathways in the future

The activities undertaken are: 

  • Baseline assessments of MRCZ and selected IRBs
  • Detailed review of relevant legislation, policies, and operational instruments
  • Stakeholder consultations in Harare and Bulawayo to gather national insights on proposed reforms
  • Independent expert assessments and site visits to IRBs and research institutions
  • Development of a sustainable financing and resourcing model for MRCZ
  • Initiation of digital transformation processes for MCAZ and MRCZ in preparation for integrated workflow systems.
MODERNISING MEDICAL RESEARCH FRAMEWORK AMID DIGITAL TRANSFORMATION

MODERNISING MEDICAL RESEARCH FRAMEWORK AMID DIGITAL TRANSFORMATION

HARARE – JUNE 19, 2025  Zimbabwe is modernizing its medical research governance and accelerating digital…

Our Contact